|
|
Zeltia SA - Comparative Business Analysis Snapshot
Business Description
Zeltia SA(ZELTIA). The Group's principal activities are to manufacture and market chemical and bio-pharmaceutical products. The products include pesticides, vaccines, life saving drugs, paints and other decoration materials, clinical diagnostic kits etc. The Group has a research and development division that incorporates the areas of drug discovery, chemistry of natural products and synthesis and has over 580 patents in its portfolio. The Group is also involved in the acquisition and refurbishment of real estate for lease.
Competitor Analysis
This analysis compares Zeltia SA with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
